Stem Cell Patch Repairs Damaged Hearts
|
By HospiMedica International staff writers Posted on 06 Nov 2009 |
A newly identified human cardiac master stem cell is being used to artificially create a strip of ventricular heart muscle tissue that essentially works "like slapping a Band-Aid on the heart.”
Researchers at the Harvard Stem Cell Institute (HSCI, Boston, MA, USA) employed a two-colored fluorescent reporter system to isolate first and second heart field (FHF and SHF, respectively) progenitor cells from developing mouse embryos and embryonic stem cells; genome-wide profiling of coding and noncoding transcripts revealed the distinct molecular signatures of these progenitor populations. The researchers then identified a committed ventricular progenitor cell in lineage that was capable of limited in vitro expansion, differentiation, and assembly into functional ventricular muscle tissue, representing a combination of tissue engineering and stem cell biology. The committed ventricular progenitor cell was then grown into a patch of tissue on a thin layer of polymer film, using technology first developed for the manufacture of microelectronic components; once placed on the film, the cells reorganized themselves spontaneously to form a section of cardiac tissue. The created heart muscle tissue was implanted into mice where the ventricular muscle had died, and the dimensions of the piece of were controlled by limiting their growth into the heart. The researchers added that other questions would have to be answered before the stem cell technology could be put to medical use, such as how to create an appropriate blood supply for the grafted heart muscle tissue. The study was published online on October 15, 2009 in Science.
"What we would like to do now is find new ways to deliver a heart patch that is three-dimensional; for doing this in animals, I anticipate being able to do some version of this in the coming year,” said lead author Kenneth Chien, M.D., Ph.D., director of the Massachusetts General Center for Cardiovascular Research (CVRC, Boston, USA) and a member of the HSCI. "Talking clinically, I believe that in five years or so the groundwork would be laid for very early clinical studies to deliver these cells to humans.”
One possibility of the new technology is that the ventricular patch would be placed over the area of tissue damaged by a heart attack (much like a plaster), where it would expand and grow into working heart muscle. Another is that the cells would be injected into the damaged area, with the hope that they would grow to form healthy new tissue.
Related Links:
Harvard Stem Cell Institute
Massachusetts General Center for Cardiovascular Research
Researchers at the Harvard Stem Cell Institute (HSCI, Boston, MA, USA) employed a two-colored fluorescent reporter system to isolate first and second heart field (FHF and SHF, respectively) progenitor cells from developing mouse embryos and embryonic stem cells; genome-wide profiling of coding and noncoding transcripts revealed the distinct molecular signatures of these progenitor populations. The researchers then identified a committed ventricular progenitor cell in lineage that was capable of limited in vitro expansion, differentiation, and assembly into functional ventricular muscle tissue, representing a combination of tissue engineering and stem cell biology. The committed ventricular progenitor cell was then grown into a patch of tissue on a thin layer of polymer film, using technology first developed for the manufacture of microelectronic components; once placed on the film, the cells reorganized themselves spontaneously to form a section of cardiac tissue. The created heart muscle tissue was implanted into mice where the ventricular muscle had died, and the dimensions of the piece of were controlled by limiting their growth into the heart. The researchers added that other questions would have to be answered before the stem cell technology could be put to medical use, such as how to create an appropriate blood supply for the grafted heart muscle tissue. The study was published online on October 15, 2009 in Science.
"What we would like to do now is find new ways to deliver a heart patch that is three-dimensional; for doing this in animals, I anticipate being able to do some version of this in the coming year,” said lead author Kenneth Chien, M.D., Ph.D., director of the Massachusetts General Center for Cardiovascular Research (CVRC, Boston, USA) and a member of the HSCI. "Talking clinically, I believe that in five years or so the groundwork would be laid for very early clinical studies to deliver these cells to humans.”
One possibility of the new technology is that the ventricular patch would be placed over the area of tissue damaged by a heart attack (much like a plaster), where it would expand and grow into working heart muscle. Another is that the cells would be injected into the damaged area, with the hope that they would grow to form healthy new tissue.
Related Links:
Harvard Stem Cell Institute
Massachusetts General Center for Cardiovascular Research
Latest Critical Care News
- Smartphone Heart Rhythm App Reduces Unnecessary Cardioversion Procedures
- Bedside CSF Monitor Detects Early Infection in Fluid Drains
- Wearable Ultrasound Patch Noninvasively Paces Heart to Stabilize Arrhythmias
- New Practice Guidance Supports Prostatic Artery Embolization for BPH Symptoms
- AI ECG Tool Detects Cardiac Amyloidosis for Early Screening
- Cuffless Wearable Enables Continuous Blood Pressure Monitoring for Hypertension Care
- AI-Guided System Supports Cardiac Ultrasound Training on Cart-Based Systems
- AI ECG Index Tracks Pubertal Maturation in Children and Adolescents
- Noninvasive AI Tool Enables Pressure-Guided Heart Failure Management
- Regenerative Therapies Aim to Support Recovery After Traumatic Brain Injury
- Ring-Type Cuffless Monitor Becomes First Added to Official Hypertension Guidelines
- “Intelligent Tattoo” Method Detects Early Melanoma Signals
- Implantable Wireless Light Device Advances Bladder Cancer Treatment
- Reusable Intermittent Catheters Reduce Antibiotic Use Without Increasing Urinary Tract Infections
- Smart Wristband Technology Detects Cardiac Arrest and Alerts Responders
- FDA-Cleared Home Sleep Test Enables Multi-Night Diagnosis of Sleep Apnea
Channels
Artificial Intelligence
view channel
AI Platform Supports Noninvasive Remote Hemodynamic Monitoring in Heart Failure
Heart failure remains a leading cause of hospitalization in adults over 65, affecting more than 6.7 million people in the U.S. Clinicians often lose visibility into hemodynamic deterioration once patients... Read more
AI Tool Predicts Unplanned Care and Symptom Burden in Cancer Survivors
Unplanned emergency visits and hospitalizations remain common in cancer survivorship, when routine clinical contact often tapers while new symptoms emerge. These events reflect unmet needs and disrupt... Read moreSurgical Techniques
view channel
CE-Marked Ultrasonic Shears Streamline Breast and Thyroid Surgery
Thyroid and breast surgeries are often performed in confined anatomical spaces near critical structures, making precise dissection and controlled thermal management essential. As the global disease burden... Read more
3D Map of Heart Electrical Wiring Aims to Guide Congenital Heart Repair
Tetralogy of Fallot is one of the most common congenital heart problems and often requires surgery in infancy. Many survivors later develop conduction abnormalities because the cardiac electrical system... Read morePatient Care
view channel
AI Avatar Doctor Improves Patient Understanding Before Radiotherapy
Radiation oncology consultations require patients to grasp complex concepts quickly, yet anxiety and information overload often undermine understanding and informed consent. Poor comprehension can also... Read more
Wearable Sleep Data Predict Adherence to Pulmonary Rehabilitation
Chronic obstructive pulmonary disease (COPD) is a long-term lung disorder that makes breathing difficult and often disturbs sleep, reducing energy for daily activities. Limited engagement in pulmonary... Read moreHealth IT
view channel
AI-Native EHR Achieves EU Medical Device Certification
InterSystems (Boston, MA, USA) announced that its IntelliCare electronic health record (EHR) solutions have been certified as Class IIa medical devices under the European Union Medical Device Regulation... Read more
EHR-Integrated Screening Workflow Detects Cognitive Impairment at Admission
Cognitive impairment involves difficulties with thinking, learning, memory, and decision-making, and is more common in older adults. In U.S. hospitals, more than 40% of admitted older adults have dementia,... Read morePoint of Care
view channel
Portable MRI System Accelerates Emergency Brain Imaging and Triage
Emergency departments frequently face delays accessing conventional magnetic resonance imaging (MRI) for patients with suspected neurological emergencies. Such waits can slow triage, prolong boarding,... Read more







